Why the study?
Does neuraxial anesthesia reduce 0-to-30-day mortality in patients undergoing surgery with an intermediate-to-high cardiac risk compared with general anesthesia?
Does neuraxial anesthesia reduce 0-to-30-day mortality in patients undergoing surgery with an intermediate-to-high cardiac risk compared with general anesthesia?
Neuraxial anesthesia may offer a short-term mortality benefit over general anesthesia in patients with elevated cardiac risk undergoing surgery, though definitive large-scale RCTs are still needed.
Answers are grounded in this paper and cite their sources.
May support neuraxial anesthesia consideration in intermediate-to-high cardiac risk surgery; hypothesis-generating and requires confirmatory RCTs.
Compared with general anesthesia, neuraxial anesthesia may reduce the 0-to-30-day mortality for patients undergoing a surgery with an intermediate-to-high cardiac risk (level of evidence moderate). Large randomized controlled trials on the difference in death and major outcomes between regional and general anesthesia are required.
No takes yet. Share an insight, caveat, or question.
Guay et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: